Table 3.
Direct costs of HCV according to the type of treatment. Costs are expressed in PPP$.
| Treatment | Genotype | Hospitalization | Diagnosis Test | Physician Visit | Laboratory Test | Medication | Total cost | |
|---|---|---|---|---|---|---|---|---|
| Interferon + Ribavirin | Unknown | 36 (1.08) | 128 (3.79) | 385 (11.37) | 1,067 (31.55) * | 1,765 (52.21) | 3,381 (100) | |
| 1a | 39 (1.00) | 78 (1.97) | 298 (7.56) | 1,331 (33.81) * | 2,191 (55.66) | 3,936 (100) | ||
| 1b | 37 (0.76) | 74 (1.55) | 348 (7.23) | 1,788 (37.21) * | 2,560 (53.25) | 4,807 (100) | ||
| 3a | 20 (0.53) | 77 (2.06) | 248 (6.63) | 2,272 (60.82) * | 1,119 (29.95) | 3,735 (100) | ||
| 3b | 74 (1.64) | 117 (2.61) | 227 (5.04) | 2,166 (48.12) * | 1,916 (42.59) | 4,501 (100) | ||
| Total | 35 (0.92) | 97 (2.53) | 329 (8.55) | 1,483 (38.52) | 1,905 (49.49) † | 3,850 (100) † | ||
| Peg + Ribavirin | Unknown | 37 (0.24) | 144 (0.94) * | 440 (2.87) * | 1,368 (8.92) * | 13,349 (87.04) * | 15,337 (100) * | |
| 1a | 28 (0.18) | 62 (0.42) * | 194 (1.29) * | 1,352 (8.99) * | 13,413 (89.12) * | 15,050 (100) * | ||
| 1b | 16 (0.05) | 25 (0.08) * | 206 (0.65) * | 1,654 (5.24) * | 29,692 (93.99) * | 31,592 (100) * | ||
| 3a | 23 (0.17) | 50 (0.37) * | 249 (1.86) * | 2,595 (19.38) * | 10,476 (78.22) * | 13,393 (100) * | ||
| Total | 27 (0.17) | 75 (0.46) | 276 (1.67) | 1,781 (10.80) | 14,334 (86.90) † | 16,494 (100) † | ||
| Total | 32 (0.33) | 87 (0.91) | 305 (3.18) | 1,619 (16.87) | 7,554 (78.72) | 9,597 (100) |
†
Statistical significant among total cost of HCV at P<0.05.
*
Statistical significant among genotypes of HCV at P<0.05.